Miriam Michelle Berrey,Robert G. Hindes,William T. Symonds,Adrian S. Ray,Hongmei Mo,Christy M. Hebner
申请号：
US13661509
公开号：
US20130109647A1
申请日:
2012.10.26
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Disclosed herein is a method of treating a subject infected with hepatitis C virus, said method comprising administering to the subject for a time period an effective amount of GS-7977 and an effective amount of ribavirin. In one aspect, the method comprises administering to the subject an interferon-free treatment regimen comprising an effective amount of GS-7977 and an effective amount of ribavirin. In a particular aspect, the method is sufficient to produce an undetectable amount of HCV RNA in the subject for at least 12 weeks after the end of the time period. Also disclosed herein is a composition useful for the treatment of hepatitis C virus infection, said composition comprising an effective amount of GS-7977 and an effective amount of ribavirin.
